NF1 is the third most prevalent mutated or deleted gene in glioblastoma,12 fourth most mutated gene in ovarian cancer,13 and the second most common mutated tumor suppressor in lung adenocarcinoma.14 More recently, clinical evidence has mounted demonstrating that women with NF have a significantly increased breast cancer risk. This evidence concerns the gene NF1 and breast carcinoma.